Poland· PL-100176440
Erazaban 10% krem
A docosanol product containing docosanolum, registered in Poland by Phoenix Healthcare Ltd. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Docosanol is registered in 5 of 19 countries.
Countries holding a registration under ATC D06BB11 (docosanol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Docosanol · ATC D06BB11
5 / 19 countries
- Belgiumprice
- Franceprice
- Polandprice
- Spainprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Docosanolum
- Manufacturer
- Phoenix Healthcare Ltd
- Country
- Poland (PL)
- ATC code
- D06BB11
- ATC class
- Docosanol
- Defined daily dose
- 50 mg, T
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990048557
- gtin05909990048564
- gtin05909991240196
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Docosanol in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesABREVAHaleon US Holdings LLC
- SpainERAZABAN 100 MG/G CREMAEngelhard Arzneimittel Gmbh & Co. Kg
- FranceERAZABAN 100 mg/g, crèmePHOENIX HEALTHCARE (IRLANDE)
- BelgiumErazaban 10 %Phoenix Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Erazaban
- Belgium · Erazaban
- France · Erazaban
- United Kingdom (Northern Ireland) · Cold Sore, Docosanol Dendron Brands
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae557da8-19c8-412b-8748-e92678c41440 GET /v1/drugs/ae557da8-19c8-412b-8748-e92678c41440?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "100 mg/g",
"packaging": "05909990048557 ¦ OTC ¦ 36022\n1 tuba 2 g\n05909990048564 ¦ OTC ¦ 36023\n1 tuba 5 g\n05909991240196 ¦ OTC ¦ 111268\n1 tuba 15 g",
"substance": "Doconazolum 100 mg",
"common_name": "Docosanolum",
"pl_product_id": "100176440",
"pozwolenie_nr": "12856",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about docosanol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.